Kenneth Ellenbogen, MD, detailed some of the biggest trends he saw at the three-day event in New Orleans. 

New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

The newly approved device is powered by Bluetooth technology and available with a three- or six-year battery.